CCN5 (cellular communication network factor 5) is a matricellular protein that serves as a critical regulator of fibrosis, metabolism, and cellular differentiation across multiple organ systems. CCN5 functions primarily as an anti-fibrotic agent by inhibiting TGF-β signaling pathways through direct interaction with Smad3, preventing its nuclear translocation and downstream target gene activation 1. The protein also modulates Wnt/β-catenin signaling, which is essential for its regulatory effects on fibrosis and metabolic processes 1. In metabolic regulation, CCN5 acts as a positive regulator of insulin sensitivity and lean body mass while inhibiting adipocyte hypertrophy and lipid accumulation 23. CCN5 demonstrates protective cardiovascular effects by promoting endothelial repair through thymosin β4 interactions and suppressing vascular smooth muscle cell proliferation, thereby preventing restenosis 4. The protein exhibits therapeutic potential in cardiac dysfunction, where modRNA-mediated CCN5 delivery significantly attenuates cardiac fibrosis and improves function following myocardial infarction 5. CCN5 expression is hormonally regulated, being upregulated by estrogens through functional estrogen response elements in its promoter region 6. In disease contexts, CCN5 plays complex roles in cancer progression that vary by tumor type and appears to drive testicular aging through fibrosis promotion and lipid dysregulation 78.